KR20040029012A - 안내압항진 및 녹내장 치료용 방법 및 조성물 - Google Patents

안내압항진 및 녹내장 치료용 방법 및 조성물 Download PDF

Info

Publication number
KR20040029012A
KR20040029012A KR10-2004-7002670A KR20047002670A KR20040029012A KR 20040029012 A KR20040029012 A KR 20040029012A KR 20047002670 A KR20047002670 A KR 20047002670A KR 20040029012 A KR20040029012 A KR 20040029012A
Authority
KR
South Korea
Prior art keywords
keto
prostaglandin compound
dihydro
alkyl
composition
Prior art date
Application number
KR10-2004-7002670A
Other languages
English (en)
Korean (ko)
Inventor
우에노류지
Original Assignee
수캄포 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 수캄포 아게 filed Critical 수캄포 아게
Publication of KR20040029012A publication Critical patent/KR20040029012A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR10-2004-7002670A 2001-08-23 2002-08-22 안내압항진 및 녹내장 치료용 방법 및 조성물 KR20040029012A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31411001P 2001-08-23 2001-08-23
US60/314,110 2001-08-23
PCT/JP2002/008446 WO2003018025A1 (en) 2001-08-23 2002-08-22 Method and composition for treatment of ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
KR20040029012A true KR20040029012A (ko) 2004-04-03

Family

ID=23218598

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7002670A KR20040029012A (ko) 2001-08-23 2002-08-22 안내압항진 및 녹내장 치료용 방법 및 조성물

Country Status (12)

Country Link
US (1) US20030060511A1 (es)
EP (1) EP1420793A1 (es)
JP (1) JP2004521960A (es)
KR (1) KR20040029012A (es)
CN (1) CN1575178A (es)
AR (1) AR036276A1 (es)
BR (1) BR0205932A (es)
CA (1) CA2458230A1 (es)
MX (1) MXPA04001604A (es)
NO (1) NO20031779L (es)
WO (1) WO2003018025A1 (es)
ZA (1) ZA200302911B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003215820A1 (en) * 2002-03-28 2003-10-13 Sucampo Ag Method for treating ocular hypertension and glaucoma
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
KR20140035363A (ko) * 2011-04-07 2014-03-21 수캄포 아게 안정피로 치료 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932389A (en) * 1974-12-11 1976-01-13 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
ES2213504T1 (es) * 1988-09-06 2004-09-01 Pfizer Health Ab Derivados de prostaglandina para el tratamiento del glaucoma o hipertension ocular.
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) * 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP0580268B1 (en) * 1988-10-01 1998-01-14 R-Tech Ueno Ltd. Ocular hypotensive agents
US5194429A (en) * 1988-10-01 1993-03-16 K.K. Ueno Seiyaku Oyo Kenkyujo Ocular hypotensive agents
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
CA2042972C (en) * 1990-05-22 1996-10-15 Ryuji Ueno Treatment of ocular hypertension with a synergistic combination for ocular administration
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension

Also Published As

Publication number Publication date
NO20031779D0 (no) 2003-04-22
JP2004521960A (ja) 2004-07-22
ZA200302911B (en) 2003-10-14
CN1575178A (zh) 2005-02-02
EP1420793A1 (en) 2004-05-26
MXPA04001604A (es) 2004-07-08
CA2458230A1 (en) 2003-03-06
US20030060511A1 (en) 2003-03-27
AR036276A1 (es) 2004-08-25
NO20031779L (no) 2003-04-22
BR0205932A (pt) 2004-02-17
WO2003018025A1 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
JP5686819B2 (ja) 黄斑浮腫を処置するための医薬組成物
JP2012197308A (ja) 眼科用組成物
EP1317269A2 (en) Composition containing a 15-keto prostaglandin compound for treating of ocular hypertension and glaucoma
EP1562604B1 (en) Prostaglandin compounds for the treatment of obesity
KR960010437B1 (ko) 상승병용을 이용한 안고혈압 치료
US8889735B2 (en) Method for treating asthenopia
US20050014837A1 (en) Method for treating ocular hypertension and glaucoma
KR20040029012A (ko) 안내압항진 및 녹내장 치료용 방법 및 조성물
KR20040023707A (ko) 안내압항진 및 녹내장의 치료
US20040225014A1 (en) Method for treating ocular hypertension and glaucoma
AU2002326160A1 (en) Method and composition for treatment of ocular hypertension and glaucoma
US20030220396A1 (en) Method for treating ocular hypertension and glaucoma
US20040254247A1 (en) Method and composition for treatnment of ocular hypertension and glaucoma
AU2002355693A1 (en) Treatment of ocular hypertension and glaucoma
AU2002255346A1 (en) Method for treatingocular hypertension and glaucoma

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid